Human immunoglobulin G levels of viruses and associated glioma risk
Abstract Few consistent etiological factors have been identified for primary brain tumors. Inverse associations to asthma and low levels of varicella-zoster virus, immunoglobulin (Ig) levels in prevalent cases have indicted a role for the immune system in the development of glioma. Because samples from prevalent cases of glioma could be influenced by treatments such as steroids and chemotherapy, we investigated pre-diagnostic samples from three large Scandinavian cohorts. To test the hypothesis that immune response levels to these viruses are associated etiologically with glioma risk, we investigated pre-diagnostic immunoglobulin levels for cytomegalovirus (CMV), varicella-zoster virus (VZV), adenovirus (Ad), and Epstein-Barr virus (EBV) including the nuclear antigen (EBNA1) using plasma samples from 197 cases of adult glioma and 394 controls collected from population-based cohorts in Sweden and Denmark. Low VZV IgG levels were marginally significantly more common in glioma cases than the controls (odds ratio (OR) = 0.68, 95% CI 0.41–1.13) for the fourth compared with the first quartile (p = 0.06 for trend). These results were more prominent when analyzing cases with blood sampling at least 2 years before diagnosis (OR = 0.63, 95% CI 0.37–1.08) (p = 0.03). No association with glioma risk was observed for CMV, EBV, and adenovirus..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
Cancer causes & control - 22(2011), 9 vom: 30. Juni, Seite 1259-1266 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sjöström, Sara [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
BKL: | |
---|---|
Themen: |
doi: |
10.1007/s10552-011-9799-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR011191201 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR011191201 | ||
003 | DE-627 | ||
005 | 20230519164943.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201005s2011 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10552-011-9799-3 |2 doi | |
035 | |a (DE-627)SPR011191201 | ||
035 | |a (SPR)s10552-011-9799-3-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.81 |2 bkl | ||
100 | 1 | |a Sjöström, Sara |e verfasserin |4 aut | |
245 | 1 | 0 | |a Human immunoglobulin G levels of viruses and associated glioma risk |
264 | 1 | |c 2011 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Few consistent etiological factors have been identified for primary brain tumors. Inverse associations to asthma and low levels of varicella-zoster virus, immunoglobulin (Ig) levels in prevalent cases have indicted a role for the immune system in the development of glioma. Because samples from prevalent cases of glioma could be influenced by treatments such as steroids and chemotherapy, we investigated pre-diagnostic samples from three large Scandinavian cohorts. To test the hypothesis that immune response levels to these viruses are associated etiologically with glioma risk, we investigated pre-diagnostic immunoglobulin levels for cytomegalovirus (CMV), varicella-zoster virus (VZV), adenovirus (Ad), and Epstein-Barr virus (EBV) including the nuclear antigen (EBNA1) using plasma samples from 197 cases of adult glioma and 394 controls collected from population-based cohorts in Sweden and Denmark. Low VZV IgG levels were marginally significantly more common in glioma cases than the controls (odds ratio (OR) = 0.68, 95% CI 0.41–1.13) for the fourth compared with the first quartile (p = 0.06 for trend). These results were more prominent when analyzing cases with blood sampling at least 2 years before diagnosis (OR = 0.63, 95% CI 0.37–1.08) (p = 0.03). No association with glioma risk was observed for CMV, EBV, and adenovirus. | ||
650 | 4 | |a Glioma |7 (dpeaa)DE-He213 | |
650 | 4 | |a Glioblastoma |7 (dpeaa)DE-He213 | |
650 | 4 | |a Immunoglobulin G |7 (dpeaa)DE-He213 | |
650 | 4 | |a Virus |7 (dpeaa)DE-He213 | |
650 | 4 | |a Case–control study |7 (dpeaa)DE-He213 | |
700 | 1 | |a Hjalmars, Ulf |e verfasserin |4 aut | |
700 | 1 | |a Juto, Per |e verfasserin |4 aut | |
700 | 1 | |a Wadell, Göran |e verfasserin |4 aut | |
700 | 1 | |a Hallmans, Göran |e verfasserin |4 aut | |
700 | 1 | |a Tjönneland, Anne |e verfasserin |4 aut | |
700 | 1 | |a Halkjaer, Jytte |e verfasserin |4 aut | |
700 | 1 | |a Manjer, Jonas |e verfasserin |4 aut | |
700 | 1 | |a Almquist, Martin |e verfasserin |4 aut | |
700 | 1 | |a Melin, Beatrice S. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer causes & control |d Dordrecht [u.a.] : Springer Science + Business Media B.V., 1990 |g 22(2011), 9 vom: 30. Juni, Seite 1259-1266 |w (DE-627)SPR011181532 |w (DE-600)1496544-6 |x 1573-7225 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2011 |g number:9 |g day:30 |g month:06 |g pages:1259-1266 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10552-011-9799-3 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.81 |q ASE |
951 | |a AR | ||
952 | |d 22 |j 2011 |e 9 |b 30 |c 06 |h 1259-1266 |